Purchase or Partnership Up Next for Hepatitis C Firms?
BioWorld Insight Contributing Writer
The annual meeting of the American Association for the Study of Liver Diseases kicks off this week, but biotechs with hepatitis C drugs may be busier talking with potential partners than with hepatologists during the event.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter